Jérôme Andries is a finance executive with over 30 years of international experience in the pharmaceutical and biotech sectors. His expertise spans from finance, accounting, strategic planning and business development.
In his most recent role, as Head of Finance for GSK's R&D organization, he was a key member of the R&D leadership team and of the various R&D investment boards, where he led portfolio prioritizations and fostered external collaborations.
Additionally, Jérôme served as director for the IP holding GSK entities. Prior to this, he was the CFO for ViiV Healthcare, a global specialist HIV company, where he managed finance growth, business development, and played a pivotal role in ensuring global drug supply through flexible pricing and partnerships.
Earlier in his career, Jérôme served as the European CFO for Eli Lilly and Company (Lilly) and held various finance and business development roles of increasing responsibility at both Lilly and Hoechst Marion Roussel across Europe, Asia and the Middle-East, gaining broad cross-market experience.
As HAYA’s CFO, he will drive financial strategy and strengthen our financial foundations, ensuring HAYA's sustainable growth and value creation, as we scale across geographies and advance our pipeline of cell state reprogramming medicines.
